Physicians' Opinion on Asymptomatic Reflux Esophagitis and Short Segment Barrett's Esophagus |
Jung Hee Kim, Jun Haeng Lee, Dong Ho Lee |
1Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. stomachlee@gmail.com 2Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea. |
무증상 역류성 식도염과 단분절 바렛식도에 대한 의료진의 견해 |
김정희, 이준행, 이동호1 |
성균관대학교 의과대학 삼성서울병원 내과, 서울대학교 의과대학 분당서울대학교병원 내과1 |
|
Abstract |
BACKGROUND/AIMS There are controversies on the management of asymptomatic reflux esophagitis and short-segment Barrett's esophagus in Korea. MATERIALS AND METHODS: From October 2012 to February 2013, an iPAD app-based survey for 10 questions about asymptomatic reflux esophagitis and short segment Barrett's esophagus was performed. A total of 585 physicians, most of them primary care physicians, answered the survey. RESULTS: For asymptomatic individuals with LA group A reflux esophagitis, physicians recommend non-pharmacologic treatment in 46.2%, proton pump inhibitor (PPI) in 33.8%, and histamine-2 receptor antagonists (H2RA) in 17.3%. For asymptomatic individuals with LA group B reflux esophagitis, physicians recommend PPI in 51.5%, non-pharmacologic treatment in 27.0%, and H2RA in 20.6%. The proportion of non-pharmacologic treatment in LA group A and B was statistically significant (P<0.01). For endoscopically suspected columnar metaplasia less than 1 cm, 50.4% of respondents answered that they would take biopsies. For patients with histologically confirmed Barrett's esophagus, 83.7 percent of respondents answered that they would prescribe PPI or H2RA, but the duration of anti-acid treatment was mostly for a couple of months only. CONCLUSIONS: There is great discrepancy on the management of asymptomatic reflux esophagitis and short segment Barrett's esophagus in Korea. |
Key Words:
Gastrointestinal reflux disease; Barrett's esophagus |
|